|
|
The concept of Diabetes & CV risk
|
|
|
|
Heart Protection Study: Impact of Diabetes on CV outcome
|
|
|
|
|
|
Cholesterol in China (2000-2001)
|
|
|
|
Diabetes in China : 1994-2008
|
|
|
|
Potentially Modifiable Risk Factorsand MI
|
|
|
|
Temporal Mortality Trends
|
|
|
|
Atherosclerosis:Risk Reduction Strategy Lifetime Risk
|
|
|
|
CARDS: Cumulative Hazard for MI and CV death
|
|
|
|
|
|
|
MRFIT)
|
|
|
|
Steno-2 Study in T2 DM: CV Outcome*
|
|
|
|
Atherosclerosis: ‘Investing in your Arteries’
|
|
|
|
Coronary Heart Disease Mortality in Beijing 1984-1999
|
|
|
|
Prevalence of Atherosclerosis by Donor Age
|
|
|
|
CV Risk Factors in Childhood and Carotid IMT in Adults
|
|
|
|
Framingham Heart Study Lifetime Risk
|
|
|
|
Age and CV Risk in Diabetes
|
|
|
|
LDL Cholesterol and Coronary Heart Disease
|
|
|
|
Primary Prevention: Influence of Age
|
|
|
|
High-Normal BP and CVD Risk
|
|
|
|
Beyond BP?
|
|
|
|
BP Treatment in Type 2 DM
|
|
|
|
TROPHY Study: ARB in ‘Prehypertension’
|
|
|
|
|
Cardiovascular Continuum: Vascular Biology Targets
|
|
|
|
RAS Blockade, Adipocytes and Diabetes
|
|
|
|
|
|
Benefit of Treating the Metabolic Syndrome
|
|
|
|
|
|
|
|
|
CV Risk Management-Long way to go?
|
|
Risk Deanfield SH 2011 (PPTX 2.7MB)
Share this page with your colleagues and friends: